UW: New study links inhaled corticosteroids to sleep apnea
Madison, Wis. — Inhaled corticosteroids such as fluticasone may quell the symptoms of asthma, but a recently published University of Wisconsin-Madison pilot study suggests that in some people, these inhaled drugs make the throat and tongue more floppy, promoting sleep apnea.
Physicians are learning that patients with asthma more often have sleep apnea – a breathing disturbance often marked by snoring. It had not been fully appreciated how asthma, which primarily affects the lungs, could cause sleep apnea, which occurs when the throat and soft palate relax so much they block the airway. Physicians have long recognized that corticosteroid pills or injectables can lead to muscle weakness and fat accumulation, but had inadequate data about the impact of the orally inhaled corticosteroids on the upper part of the airway, in the throat. This part of the airway is vulnerable and is formed only of muscles.
This pilot study suggests the culprit may be these widely prescribed inhaled corticosteroids, taken by millions to control asthma. Lead author Dr. Mihaela Teodorescu, associate professor of medicine at the UW School of Medicine and Public Health, says that her earlier studies confirmed that 75 percent of asthma patients were taking these medications. Common brand names of inhalers that contain fluticasone are Flovent and Advair.
“In the lungs, corticosteroids reduce airway inflammation, but no one has studied how they affect the pharyngeal upper airway,” says Teodorescu, who practices pulmonary medicine at the William S. Middleton Veterans Hospital and UW Hospital and Clinics.
The study involved 18 subjects, many of them college-aged women with asthma. They were treated with 16 weeks of fluticasone, and were monitored for changes in the collapsibility of their upper airways during sleep and in their tongue function while awake. In three patients, researchers measured the amount of fat in their soft palates via magnetic resonance imaging (MRI). In addition, asthma control was monitored.
Researchers found that the older male subjects with poor asthma control demonstrated deterioration in their upper airway collapsibility. In general, all subjects had changes in tongue function consistent with sleep apnea. Teodorescu also noted that all three subjects who underwent the MRI scan had increased fat content around their airway, compared to baseline. On average, the fraction of tissue composed of fat increased by 20.6 percent and fat volume increased by 15.4 percent.
“We found that they redistribute fat to the neck area, where it likely presses on and narrows the upper airway,” she says.
Teodorescu cautions that the results need to be replicated in a larger study. She notes that inhaled corticosteroids have become a very important tool for controlling asthma in the 18 million Americans with this respiratory disorder. But she says the results have made her more conservative in how she prescribes inhaled corticosteroids for her own patients.
“I think it’s a good idea to limit these medications to the lowest dose necessary to achieve or maintain control,” she says.
Teodorescu’s collaborators include Dr. Christine Sorkness of the UW School of Pharmacy and Dr. Atul Malhotra of the University of California-San Diego.
The study was published this week in the Journal of Clinical Sleep Medicine. A link is available here: http://www.aasmnet.org/jcsm/
#
This research was funded by the National Institutes for Health grant 1 U10 Hl074212-01 from the NIH-NHLBI Asthma Clinical Research Network, with additional resources from the William S. Middleton Memorial VA Hospital, Madison, Wisconsin.
